+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Paratek Pharmaceuticals - logo

Paratek Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of therapeutics based upon tetracycline chemistry. Its lead product candidates include Omadacycline and Sarecycline, both of which are undergoing clinical trials. It has collaborative research and license agreement with Allergan plc to research and develop tetracycline products. Paratek was incorporated in 2001 and is based in Boston, Massachusetts.

Nontuberculous Mycobacteria (NTM) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Nontuberculous Mycobacteria (NTM) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • June 2022
  • 66 Pages
  • Global
From
Pyelonephritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Pyelonephritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 150 Pages
  • Global
From
Escherichia Coli Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Escherichia Coli Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 200 Pages
  • Global
From
Anthrax - Pipeline Review, H2 2020 - Product Thumbnail Image

Anthrax - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 126 Pages
  • Global
From
Insomnia Therapeutics Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Insomnia Therapeutics Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application

  • Report
  • May 2021
  • 111 Pages
  • Global
From
Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q2 2023 - Thematic Intelligence - Product Thumbnail Image

Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q2 2023 - Thematic Intelligence

  • Report
  • August 2023
  • 26 Pages
  • Global
From
Paratek Pharmaceuticals Inc (PRTK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Paratek Pharmaceuticals Inc (PRTK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Comprehensive Report on Paratek Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Paratek Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2023
  • 53 Pages
From
Loading Indicator